latest health care news


‘Thriving’ UK medicines discovery sector being driven by brand new technologies

New state-of-the-art technologies are keeping the UK competitive in a “thriving” service and supply sector in medicines discovery, a 2019 State of the Discovery Nation report has revealed.

The research from the Medicines Discovery Catapult (MDC) and the BioIndustry Association (BIA) found 300 companies focused on discovering potential new medicine, 70% of which are working in areas of cancer, anti-infectives and central nervous systems.

The report highlights two new breakthrough technologies set to influence the future of medicines discovery, with both Artificial Intelligence (AI) and Complex Cell Models (CCMs) offering large potential.

It said the UK now has the opportunity to apply new cutting-edge science and technology to make medicines discovery more productive and maintain the UK’s global competitiveness.

The report also found that service and supply companies account for 80% of SMEs in the UK medicines discovery sector, and despite their size they are a “critical source of innovation for new medicines.”

Chris Molloy, chief executive officer of Medicines Discovery Catapult, said the UK “should be proud” of the vibrancy of its thriving medicines discovery ‘community.’

He commented: “The UK cannot conduct medicines discovery without access to this diverse range of skills, technologies and expertise.

“It is vital that we maintain our global competitiveness and R&D services can be a major sector driving international trade. The report’s findings help shape our strategy at MDC and we will continue to strengthen R&D productivity to create new medicines for patients.”

Alongside the 2019 State of the Discovery Nation, the BIA’s benchmarking report showed that by 2025 the UK could support an extra 33,000 biotech jobs and 50 biotech companies at early clinical stage.

BIA’s chief executive officer, Steve Bates, said the report “shines a light” on an often overlooked group of companies who are vital to the sector and ecosystem.

“As such, the economic benefit in jobs and growth in UK life science, especially outside the South East of England, is often delivered via sub-contracting and the provision of services. It’s vitally important policy makers understand this network and supply chain as we work together to deliver the UK life science industrial strategy.”

The MDC report said companies are calling for government support, funding and tax incentives, with 90% saying they need AI, and 75% of AI funding is currently spent on data access and curation.

CCMs also show “much promise,” and whilst there is a need for validation before large-scale use, they could reduce animal usage drastically.

Image credit - skynesher


There are no comments. Why not be the first?

Add your comment


national health executive tv

more videos >

featured articles

View all News

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now beyond more > more last word articles >

health service focus

View all News


Turning blue lights green

11/04/2019Turning blue lights green

Polly Billington, director of UK100, a cities network that campaigns on env... more >
Going back to school at Gloucestershire Hospitals NHS Foundation Trust

10/04/2019Going back to school at Gloucestershire Hospitals NHS Foundation Trust

Steve Hams, director of quality and chief nurse at Gloucestershire Hospital... more >


How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

24/10/2018How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

A dedicated national social care service could be a potential solution to s... more >

the scalpel's daily blog

The introduction of state indemnity and the continued importance of MDO membership

22/05/2019The introduction of state indemnity and the continued importance of MDO membership

Dr Caroline Fryar, head of advisory services at the Medical Defence Union (MDU), explains why medical defence organisation (MDO) membership remains important following the int... more >
read more blog posts from 'the scalpel' >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital exemplars who were revealed at the same show 12 months earlier.  Jeremy Hunt also stated that by the end of 2018 – the 70th birthday... read more >